PubMed

Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism.

Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P.

Diabetes Care. 2002 Aug;25(8):1418-24.PMID: 12145244 [PubMed - indexed for MEDLINE]Related articlesFree article

Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism.

Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P.

Cardiovasc Diabetol. 2002 Nov 22;1:5.PMID: 12473160 [PubMed]Related articlesFree article

Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.

Gazzaruso C, Garzaniti A, Falcone C, Geroldi D, Finardi G, Fratino P.

Diabet Med. 2001 Jul;18(7):589-94.PMID: 11553191 [PubMed - indexed for MEDLINE]Related articles

Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

Avignon A, Sultan A, Piot C, Elaerts S, Cristol JP, Dupuy AM.

Diabetes Care. 2005 Sep;28(9):2176-80.PMID: 16123486 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.

Gazzaruso C, Bruno R, Pujia A, De Amici E, Fratino P, Solerte SB, Garzaniti A.

Int J Cardiol. 2006 Apr 14;108(3):354-8. Epub 2005 Jun 14.PMID: 15961173 [PubMed - indexed for MEDLINE]Related articles

Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians.

Gambhir JK, Kaur H, Prabhu KM, Morrisett JD, Gambhir DS.

Clin Biochem. 2008 May;41(7-8):453-8. Epub 2008 Feb 5.PMID: 18280807 [PubMed - indexed for MEDLINE]Related articles

Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.

Pedreño J, Fernández R, Ballester A, Jornet A, Usón M, Canela J, Petit M.

Int J Cardiol. 2000 Jul 31;74(2-3):159-67.PMID: 10962116 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients.

Gazzaruso C, Garzaniti A, Falcone C, Puija A, Geroldi D, Giordanetti S, Fratino P.

J Diabetes Complications. 2003 May-Jun;17(3):135-40.PMID: 12738397 [PubMed - indexed for MEDLINE]Related articles

Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients.

Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A.

Circulation. 2004 Jul 6;110(1):22-6. Epub 2004 Jun 21.PMID: 15210604 [PubMed - indexed for MEDLINE]Related articlesFree article

Is apolipoprotein(a) a susceptibility gene for type I diabetes mellitus and related to long-term survival?

Kronenberg F, Auinger M, Trenkwalder E, Irsigler K, Utermann G, Dieplinger H.

Diabetologia. 1999 Aug;42(8):1021-7.PMID: 10491765 [PubMed - indexed for MEDLINE]Related articles

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.

Farrer M, Game FL, Albers CJ, Neil HA, Winocour PH, Laker MF, Adams PC, Alberti KG.

Arterioscler Thromb. 1994 Aug;14(8):1272-83.PMID: 8049188 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.

Gazzaruso C, Garzaniti A, Buscaglia P, Bonetti G, Falcone C, Fratino P, Finardi G, Geroldi D.

J Am Coll Cardiol. 1999 Jan;33(1):157-63.PMID: 9935023 [PubMed - indexed for MEDLINE]Related articles

Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).

Saku K, Zhang B, Liu R, Shirai K, Arakawa K.

Jpn Circ J. 1999 Sep;63(9):659-65.PMID: 10496479 [PubMed - indexed for MEDLINE]Related articlesFree article

Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.

Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H, Kronenberg F.

J Am Soc Nephrol. 1997 Dec;8(12):1889-98.PMID: 9402091 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.

Parlavecchia M, Pancaldi A, Taramelli R, Valsania P, Galli L, Pozza G, Chierchia S, Ruotolo G.

Am J Cardiol. 1994 Aug 15;74(4):346-51.PMID: 8059696 [PubMed - indexed for MEDLINE]Related articles

Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.

Emanuele E, Peros E, Minoretti P, D'Angelo A, Piccinni MN, Montagna L, Geroldi D.

Nutr Metab Cardiovasc Dis. 2004 Aug;14(4):193-9.PMID: 15553596 [PubMed - indexed for MEDLINE]Related articles

Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes.

Koba S, Hirano T, Yoshino G, Sakai K, Sakaue T, Adachi M, Katagiri T.

Atherosclerosis. 2002 Jan;160(1):249-56.PMID: 11755944 [PubMed - indexed for MEDLINE]Related articles

Asymptomatic coronary artery disease in diabetes: relation to common risk factors, lipoproteins, apoproteins and apo E polymorphism.

Koistinen MJ, Huikuri HV, Korhonen UR, Linnaluoto MK, Kuusi T, Takkunen JT, Taskinen MR.

Acta Diabetol. 1994 Dec;31(4):210-4.PMID: 7888691 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus.

Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T, Yoshimura M, Ogawa H, Fujioka D, Kugiyama K.

J Am Coll Cardiol. 2004 Jun 16;43(12):2219-24.PMID: 15193683 [PubMed - indexed for MEDLINE]Related articles

Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.

Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F.

Atherosclerosis. 2002 Jun;162(2):381-9.PMID: 11996958 [PubMed - indexed for MEDLINE]Related articles